MM Shah, B Joyce, ID Plumb, S Sahakian… - … and Mortality Weekly …, 2022 - ncbi.nlm.nih.gov
Nirmatrelvir-ritonavir (Paxlovid), an oral antiviral treatment, is authorized for adults with mild-
to-moderate COVID-19 who are at increased risk for progression to severe illness. However …